Huadong Medicine Co Ltd (000963) — Cash Flow Reinvestment Rate
Huadong Medicine Co Ltd (000963) has a Cash Flow Reinvestment Rate of 1.90x as of September 2025, reinvesting CN¥297.09 Million (capex CN¥297.09 Million ) from operating cash flow of CN¥155.98 Million. Check Huadong Medicine Co Ltd (000963) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Huadong Medicine Co Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for Huadong Medicine Co Ltd across 26 annual periods. Explore 000963 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Huadong Medicine Co Ltd (1998–2024)
Year-by-year capital reinvestment analysis for Huadong Medicine Co Ltd. For live market cap and broader valuation context, see market cap of Huadong Medicine Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.47x | CN¥1.75 Billion | CN¥3.75 Billion | CN¥1.73 Billion | ▼ -45.3% |
| 2023 | 0.85x | CN¥3.36 Billion | CN¥3.93 Billion | CN¥1.61 Billion | ▼ -5.0% |
| 2022 | 0.90x | CN¥2.14 Billion | CN¥2.38 Billion | CN¥1.19 Billion | ▲ +142.3% |
| 2021 | 0.37x | CN¥1.18 Billion | CN¥3.17 Billion | CN¥819.10 Million | ▼ -39.8% |
| 2020 | 0.62x | CN¥2.10 Billion | CN¥3.41 Billion | CN¥1.47 Billion | ▼ -23.4% |
| 2019 | 0.80x | CN¥1.61 Billion | CN¥2.00 Billion | CN¥1.35 Billion | ▲ +5.4% |
| 2018 | 0.76x | CN¥1.56 Billion | CN¥2.04 Billion | CN¥876.46 Million | ▲ +25.7% |
| 2017 | 0.61x | CN¥1.01 Billion | CN¥1.66 Billion | CN¥478.69 Million | ▲ +32.6% |
| 2016 | 0.46x | CN¥616.70 Million | CN¥1.35 Billion | CN¥467.00 Million | ▼ -64.0% |
| 2015 | 1.27x | CN¥837.59 Million | CN¥658.54 Million | CN¥383.01 Million | ▲ +190.0% |
| 2014 | 0.44x | CN¥324.89 Million | CN¥740.85 Million | CN¥324.89 Million | ▼ -37.7% |
| 2013 | 0.70x | CN¥335.84 Million | CN¥476.98 Million | CN¥335.84 Million | ▲ +76.1% |
| 2012 | 0.40x | CN¥256.97 Million | CN¥642.73 Million | CN¥256.97 Million | ▼ -97.1% |
| 2011 | 13.91x | CN¥224.21 Million | CN¥16.12 Million | CN¥224.21 Million | ▲ +6009.9% |
| 2009 | 0.23x | CN¥129.26 Million | CN¥567.94 Million | CN¥129.26 Million | ▼ -11.1% |
| 2008 | 0.26x | CN¥88.24 Million | CN¥344.69 Million | CN¥88.24 Million | ▲ +110.8% |
| 2007 | 0.12x | CN¥32.27 Million | CN¥265.79 Million | CN¥32.27 Million | ▼ -91.7% |
| 2006 | 1.46x | CN¥83.53 Million | CN¥57.38 Million | CN¥83.53 Million | ▲ +492.0% |
| 2005 | 0.25x | CN¥50.00 Million | CN¥203.33 Million | CN¥50.00 Million | ▼ -95.4% |
| 2004 | 5.33x | CN¥66.60 Million | CN¥12.51 Million | CN¥66.60 Million | ▲ +558.2% |
| 2003 | 0.81x | CN¥73.24 Million | CN¥90.54 Million | CN¥73.24 Million | ▼ -65.7% |
| 2002 | 2.36x | CN¥56.47 Million | CN¥23.94 Million | CN¥56.47 Million | ▲ +386.1% |
| 2001 | 0.49x | CN¥53.21 Million | CN¥109.67 Million | CN¥53.21 Million | ▼ -85.6% |
| 2000 | 3.37x | CN¥66.01 Million | CN¥19.59 Million | CN¥66.01 Million | ▲ +1565.3% |
| 1999 | 0.20x | CN¥11.40 Million | CN¥56.32 Million | CN¥11.40 Million | ▼ -62.1% |
| 1998 | 0.53x | CN¥12.70 Million | CN¥23.80 Million | CN¥12.70 Million | — |